Skip to main content
. 2016 Aug 22;6(8):e227. doi: 10.1038/nutd.2016.34

Figure 3.

Figure 3

HR for the use of T2DM medication in young adulthood in individuals who have been treated for obesity as children and adolescents. The cohort is divided according to first measured fasting glucose level, and glucose <4.5 mmol l−1 is used as a reference. The model is adjusted for gender, degree of obesity and ethnicity.